Because AEON is based on a standard logic CMOS process, it requires no additional masks or processes which eliminates the costly manufacturing steps normally involved with floating gate memory while reducing the engineering effort and associated costs of integrating NVM into SoC designs. TSMC and Virage Logic have worked together on the 65nm MTP process to bring true multi-time NVM programmability to such market segments as security and wireless where advanced process adoption is crucial, said Yankin Tanurhan, vice president and general manager, NVM Solutions, Virage Logic. With inputs from customers’ design needs, we are convinced this 65nm process is well-suited for applications that require a small memory footprint on a leading edge manufacturing technology, explains Jason Chen, vice president worldwide sales and marketing for TSMC.
Mtp 65 full#
Devices built using the process will support full read and program operations across temperatures ranging from -40 degrees C to 125 degrees C, with minimum 10-year data retention at 125 degrees C. The technology is fully logic-compatible and the NVM memory requires no additional processes or masks. The 65nm MTP process is built up to 10 metal layers using copper low-k interconnects and nickel silicide transistor interconnects. The new technology is the first 2.5 volt MTP process, breaking the heretofore 3.3 volt baseline barrier.īuilt on TSMC’s 65nm Low Power (LP) process, the new MTP technology features up to 8k bits memory size that is ideal for small memory requirements associated with MP3 music downloadable digital rights management, RFID devices, fingerprint identification applications, and pre-paid cash or phone cards. The new technology eliminates the need for an external EEPROM currently in many systems applications, thereby reducing power, area and costs while increasing data security. The technology incorporates process- qualified MTP IP blocks jointly developed with Virage Logic Corporation (Virage Logic). (TSMC) has introduced a new 65-nanometer (nm) multi-time programmable (MTP) non- volatile memory (NVM) process technology. The company was founded in 2000 and is headquartered in Cardiff, the United Kingdom.Taiwan Semiconductor Manufacturing Company, Ltd. immunotherapy - enhanced uptake of new immuno-moieties by immune cells that can then mount an immune attack against cancer cells. chemotherapy - improved and targeted delivery of existing chemotherapeutic agents to tumor sites, as well as ii. The firm's proprietary platform drug delivery technologies are Q-Sphera platform is a disruptive polymer microsphere technology, which is used for sustained release at the microscale to prolong and control the release of therapeutics over an extended period of time from weeks to months Midasolve platform is a innovative nanosaccharide technology, which is used to dissolve drugs at the nanoscale so that they can be administered in liquid form directly and locally into tumors Midacore platform is a edge gold nanoparticle technology, which is used for targeting sites of disease at the nanoscale ie i. It is focused on the research and development of medicines for rare cancers, via both in house programmes as well as partnered programmes. Midatech Pharma Plc is a drug delivery technology company.